Filters

Pp-132 manufacturers

Filters

None products found

pp-132

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
United States
GMP approvals
FDA
Comments
Indication: Amyotrophic lateral sclerosis (ALS) Clinical stage: Phase 2 Modality: Small molecule Mechanism / Target: Selective glucocorticoid receptor (GR) modulator — reduces cortisol-driven neuroinflammation in motor neuron disease; blocks GR-mediated transcription of pro-inflammatory genes Route / form: Oral tablet Differentiation: Novel GR modulation approach in ALS (unproven target); oral, once-daily administration; no CNS penetration concerns with selective GR modulator
Manufacturer #4727

Commercial-stage company specialising in glucocorticoid receptor modulation for oncology and endocrine disorders. Holds first-mover advantage with approved GR antagonist and next-generation wholly owned pipeline. Independent US-focused development and commercialisation strategy.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.